Impact of Next-Generation Sequencing Tests on Clinical Pathways for Cancer Care
AJMC,
With patients living longer thanks to new therapies, we need more accurate, sensitive, and standardized tools to guide their…
Bayesian Phase 1/2 trial designs and cellular immunotherapies: a practical primer
BioInsights,
Introduction Despite the development of many novel clinical trial designs over the past three decades, Bayesian Phase 1/2…
CAR T cell therapies in pediatric oncology: access and future development by distributed academic cell manufacturing
BioInsights,
The development of effective therapies for childhood leukemia is a major success story in medicine.
Ibrutinib Plus CAR T-Cell Therapy Boosts Response in CLL
OncLive,
Jordan Gauthier, MD, MSc Patients with relapsed/refractory chronic lymphocytic leukemia (CLL) had an improved response rate…